Zealand announces confirmatory Phase III results in hypoglycaemia
Copenhagen-based Zealand Pharma has announced positive results from a Phase III confirmatory study investigating dasiglucagon in patients with severe hypoglycaemia...
Focus:
-
![Mental Health Awareness Week: relationship between mental health and psoriasis]()
Mental Health Awareness Week: relationship between mental health and psoriasis
-
![Industry review on UK drug discovery emphasises future of AI and CCMs]()
Industry review on UK drug discovery emphasises future of AI and CCMs
-
![BMS’ Opdivo fails in Phase III glioblastoma trial]()
BMS’ Opdivo fails in Phase III glioblastoma trial
-
![Skin Cancer Awareness Month: overcoming drug resistance in skin cancer]()
Skin Cancer Awareness Month: overcoming drug resistance in skin cancer
-
![Bicycle and DDF collaborate on drug development for CNS conditions]()
Bicycle and DDF collaborate on drug development for CNS conditions
-
![World Asthma Day: can fevipiprant revolutionise asthma treatment?]()
World Asthma Day: can fevipiprant revolutionise asthma treatment?
Expert commentary & analysis from GlobalData
Takeda takes a step forward in becoming dominant player in IBD landscape
Skyrizi likely to uphold AbbVie’s position in the psoriasis market
Disclosing list prices in TV adverts will not improve US drug pricing
2018 global prescription drug sales fall against Q4 forecasts
Most Read
Company releases
Nymi to Host ‘Delivering Business Value from Biometric Security’ Webinar
The demand for increased pharmaceutical manufacturing is only offset by the growing stringent requirements by regulatory bodies for good governance...
Telstar Releases Compact Single-Vessel Freeze-Dryer
Genix Will Now Be Called Qualicaps
Genix has announced that it will now be known as Qualicaps. Acquired at the end of 2015 by Qualicaps, the Brazilian company...
Endress+Hauser Sees Significant Growth
Visit Aylward At Booth N-311 At This Year’s Pack Expo Las Vegas
Aylward has announced that it will be showcasing its solid dose packaging solutions at this year’s...
Company whitepapers
Pharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction
Malvern PanalyticalElemental Impurity Analysis in Pharmaceuticals and Implementation of ICH Q3D
Butterworth LaboratoriesPharmaceutical Cold Chain Management
Win Transport Italy9000 SERIES Bottle Filling Machine
AylwardMetformin Hydrochloride Direct Compression Pharma Application Leaflet
SigachiHow Virtualisation Can Help Electronic Data Retention
Butterworth LaboratoriesGas and Flame Detection Products
3M Gas & Flame DetectionCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Bayer’s Cell Culture Technology Centre, California, US
Bayer is building a cell culture technology centre in California for the development of biological therapies.
Vetter’s Skokie Manufacturing Facility Expansion
WuXi Biologics’ Biologics Manufacturing Centre, Shijiazhuang, China
Kite Pharma’s CAR T-cell Therapy Production Facility, Maryland
BioVectra’s Biologics Manufacturing Facility Expansion, Canada
Clinical Trials
BMS’ Opdivo fails in Phase III glioblastoma trial
Bristol-Myers Squibb (BMS) has announced that its immunotherapy drug Opdivo (nivolumab) has failed to meet its primary endpoint of overall survival (OS) in Phase III...
FDA approves paediatric LEMS drug
Bicycle and DDF collaborate on drug development for CNS conditions
FDA approves Pfizer’s drugs for transthyretin amyloid cardiomyopathy
World Asthma Day: can fevipiprant revolutionise asthma treatment?
Design
ProAmpac updates child-resistant pouch product line
Flexible packaging manufacturer ProAmpac has unveiled an updated range of child-resistant, reclosable, easy-open (CRREO) pouches in an expanded range of sizes.
Drug Development
Takeda and Frazier team up to launch biopharmaceutical firm
Takeda Pharmaceutical has collaborated with US-based Frazier Healthcare Partners to launch a biopharmaceutical company named Phathom Pharmaceuticals.
GSK expands bispecific antibodies deal with Zymeworks
New UK programme to address cancer resistance to treatments
Vertex and Kymera to identify protein degradation therapeutics
Zealand announces confirmatory Phase III results in hypoglycaemia
Market Data
Biogen’s SMA drug Spinraza to be available on NHS
The UK's National Health Service (NHS) has signed a managed access agreement to fund Biogen’s antisense oligonucleotide (ASO) Spinraza (nusinersen) for a limited time to...
AbbVie and Boehringer settle Humira biosimilar patent dispute in US
US states file lawsuit against 20 drugmakers accused of price-fixing
Study finds ART prevents HIV transmission between gay men
Hikma introduces 100th injectable medicine in US
Technology
AstraZeneca forms drug discovery alliance with BenevolentAI
AstraZeneca has partnered with artificial intelligence (AI) company BenevolentAI to develop treatments for chronic kidney disease and idiopathic pulmonary fibrosis.
PolyProx raises £3.4m in seed financing for oncology drugs
Zipline’s drone delivery of medical products expanded into Ghana
Study shows CRISPR could help treat lung disease in utero
Pfizer to use Concerto HealthAI technology for cancer treatments
Go Top